GPCR:NASDAQ, Structure Therapeutics Inc.

GPCR stock overview

Structure Therapeutics Inc. (GPCR:NASDAQ) closed at $16.13 on November 20, 2026, down 5.78% on the day. The stock trades 83.0% below its 52-week high of $94.90 and 0.3% above its 52-week low of $16.08. Over the past year, it lost 54.3%. Structure Therapeutics Inc. is part of the Health Care sector.

Key figures

Price
$16.13
Day change
-5.78%
Volume
786,126
Average volume
1,173,934
Market cap
1B+
52-week range
$16.08 – $94.90
50-day average
$25.94
200-day average
$44.24

Price action over the past year

In 252 trading sessions since November 20, 2025, GPCR closed higher on 104 days (41%). Its best day was December 8, 2025 (+102.49%) and its worst was September 8, 2026 (-14.70%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

GPCR news

About Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical stage global biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical need.

Similar stocks

Find more stocks like GPCR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.